Isomorphic Labs is an Alphabet-founded company focused on using artificial intelligence and computational methods to transform drug discovery and development. Spun out of DeepMind, it aims to build a new type of biology-inspired, AI-first pharmaceutical company that can model and design novel therapeutics more efficiently than traditional approaches.